Ocrelizumab Intravenous and UTA Capsules
Determining the interaction of Ocrelizumab Intravenous and UTA Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ocrelizumab
Brand name: Ocrevus
Synonyms: Ocrelizumab (Intravenous), Ocrelizumab
Generic Name: hyoscyamine / methenamine / methylene blue / sodium biphosphate
Brand name: Urogesic-Blue, UTA, Uro-BLUE, Urolet MB, Indiomin MB, ME/NaPhos/MB/Hyo1, UTA
Synonyms: Hyoscyamine, methenamine, methylene blue, and sodium biphosphate, Methenamine, Methylene Blue, and Sodium Phosphate Monobasic
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ocrelizumab Intravenous-UTAC tablets
- Ocrelizumab Intravenous-UTI Relief
- Ocrelizumab Intravenous-Utibron Neohaler
- Ocrelizumab Intravenous-Uticap
- Ocrelizumab Intravenous-Utira-C
- Ocrelizumab Intravenous-Utira-C Tablets
- UTA Capsules-Ocrevus
- UTA Capsules-Octagam
- UTA Capsules-Octagam Gammagard S/D
- UTA Capsules-Octocaine
- UTA Capsules-Octocaine 100
- UTA Capsules-OctreoScan